# Semaglutide

## Ozempic inj 2mg/1.5mL

##### 

| TAH Drug Code      | IOZE                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Type 2 diabetes mellitus. Prophylaxis of disorder of cardiovascular system with type 2 diabetes mellitus.                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | SC, 0.25 mg once weekly for 4 weeks, then increase to 0.5 mg once weekly; may increase to max 1 mg once weekly if additional glycemic control is needed after at least 4 weeks of the 0.5 mg weekly dosage.                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2. Known hypersensitivity to semaglutide or any component of the product.                                                                                                                                                                                                                                   |
| Adverse Effects    | Common Endocrine metabolic: Hypoglycemia (Monotherapy, 1.6% to 3.8%; combination therapy, 6% to 30% ) Gastrointestinal: Abdominal pain (5.7% to 11% ), Constipation (3.1% to 6% ), Diarrhea (8.5% to 10% ), Nausea (11% to 20.3% ), Vomiting (5% to 9.2% ) Serious Endocrine metabolic: Medullary thyroid carcinoma Gastrointestinal: Pancreatitis Immunologic: Hypersensitivity reaction Ophthalmic: Retinopathy due to diabetes mellitus |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                    |

